Stay updated on Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page footer updated to show Revision: v3.5.3, indicating a new page version. The core study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-04-30T18:42:17.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.5.2, replacing Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T11:15:00.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-18T19:28:38.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added revision v3.4.3 and removed revision v3.4.2 from the record history.
    Difference
    0.1%
    Check dated 2026-03-11T17:16:12.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed notices about government funding lapse and Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T02:07:47.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Added a site-wide maintenance notice regarding funding lapse and current operating status with links to cc.nih.gov and opm.gov. Updated the page revision identifier to v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T00:00:06.000Z thumbnail image

Stay in the know with updates to Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page.